Autoimmune drug development increasingly recognizes that the Fc-FcR axis is more than an effector mechanism; it is a controllable immunological node that bridges humoral and cellular responses. This ...
SHIRLEY, NY, UNITED STATES, February 26, 2026 /EINPresswire.com/ — Creative BioMart, a global leader in biopharmaceutical research reagents and customized services ...
In the ever changing biotherapeutics landscape, antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) success hinges on more than simply antigen recognition. While the Fab region controls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results